 Family Practice News Digital Network | SABCS: Addition of Everolimus Helps Slow Breast Cancer MedPage Today This study found that the combination of the aromatase inhibitor exemestane (Aromasin) and everolimus (Afinitor) extends progression-free survival in women diagnosed with metastatic breast cancer by more ... BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression Combination of Everolimus and Exemestane Improves Progression-Free Survival ... Novartis' Afinitor More Than Doubles PFS In Breast Cancer Patients |
